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ABSTRACT In skeletal muscle, dihydropyridine receptors
and dihydropyridine-sensitive Ca2" channels are preferentially
localized in the transverse tubular membranes. Starting with
an antigenic membrane fraction enriched in rabbit muscle
transverse tubules (T-tubules), several monoclonal antibodies
were produced by a fusion of spleen cells from an immunized
BALB/c mouse with P3 x 63Ag.8.6.5.3 mouse myeloma cells.
Antibodies were screened according to a scheme designed to
select IgG immunoglobins that recognized a determinant
specifically associated with the T-tubule membrane. Antibodies
that fulfilled the screening criteria were used in in vitro planar
bilayer recording of the activity of the dihydropyridine-sensi-
tive Ca2+ channel present in T-tubules. Cells producing one
antibody (Ab 21) survived cloning dilution and stably produced
a monoclonal antibody (mAb2l-4) that increased the rate of
single channel opening' when interacting with the internal side
of the channel protein. mAb21-4 immobilized by covalent
crosslinking on beads (Affi-Gel 10) consistently immunopre-
cipitated polypeptide bands with the following electrophoretic
mobility: M, values of 2 175,000; 90,000; 55,000; and 34,000.
Ca2+ channels are ubiquitous to almost all cell types and
participate in diverse cell functions such as motility, neuro-
transmitter and hormone release, muscle contraction, and
pacemaker activity (1). In skeletal and cardiac muscle,
identification and functional reconstitution of Ca2+ channels
has been possible with the use of dihydropyridine (DHP)
agonists and antagonists, a group of structurally related drugs
that binds with high affinity to the channel protein and
chemically modulates the opening and closing ofan otherwise
partially inactive Ca2+ channel (2-4). Using DHPs as radio-
ligands, several groups (5-8) have recently purified from
skeletal muscle of DHP-receptor-complex that has been
assumed to be associated with functional Ca2+ channels. The
DHP receptor of skeletal muscle described by Curtis and
Catteral (5) has subunits of " Mr 140,000; 50,000; and 31,000;
a similar composition has been reported by others (6-8). The
140,000 protein is the probable site of DHP binding (but see
ref. 9) and can be phosphorylated almost stoichiometrically
by cAMP kinase (8, 10).
The answer to the question of which protein components
of the DHP receptor in skeletal muscle are essential to form
a functional Ca2+ channel is unclear. Skeletal muscle has a
50- to 100-fold excess of spare DHP receptors not account-
able by the number of functional Ca2+ channels per cell (11).
Likewise, only a small percentage of the purified DHP
receptor appears to mediate drug-sensitive Ca2+ fluxes in
liposomes (3). Thus, a minor component of the purified
complex could account for Ca2+ channel activity. This, and
the long-standing disparity between ligand-binding affinity
and electrophysiological potency of the DHPs (8, 11, 12) has
limited the use of these drugs as radioligands for the Ca2+
channel protein. In the present paper, we pursued an alter-
nate approach to establish the composition offunctional Ca2+
channels in skeletal muscle. Exploiting the observation that
in skeletal muscle, the slow voltage-dependent Ca2+ currents
are predominantly concentrated in the transverse tubules
(T-tubules) (13-15), we have raised monoclonal antibodies
(mAbs) against purified T-tubule membrane constituents. We
report the production of one mAb (mAb21-4) that recognizes
a surface membrane epitope located only at the triad (formed
by anatomic coupling of the SR/T tubule membrane), pre-
sumably specific for the T-tubule. When screened for func-
tional effects on DHP-sensitive Ca2+ channels of T-tubules
(2), mAb21-4 markedly increased activity by specifically
increasing the rate of single channel opening. mAb21-4
immunoprecipitated several polypeptides with electropho-
retic mobility similar, in part, to those from the purified DHP
receptors reported by several groups (4-8).
MATERIALS AND METHODS
Isolation of Membranes. The antigenic fraction utilized in
the immunization and screening experiments was prepared
from a triad-enriched microsomal fraction as previously
described (16-18). To obtain T-tubule membranes, triads
were disrupted with 0.4 M KC1. The resultant sarcoplasmic
reticulum (SR) and T-tubule vesicles were separated accord-
ing to their differing buoyant density by isopycnic centrifu-
gation (17, 19). The T-tubule membranes were recovered
from the 22-27% sucrose region of the gradient with a purity
of ""80%, and the SR membranes were recovered from the
31-36% region of the gradient with a purity of -95% (17).
[5-methyl-3H]PN200-110 (New England Nuclear) binding
measurements (16) indicated 60 pmol of high-affinity DHP
binding sites per mg of protein. A somewhat less pure surface
membrane-enriched fraction (50 pmol of [3H]PN200-110
binding sites per mg of protein) was utilized as a source of
protein for the immunoprecipitation studies. This fraction
was recovered from the 20-27% region of a sucrose gradient
that contained membranes sedimenting at 2600-35,000 x g
(18).
Production of Antibodies and Screening Assays. Sendai
virus-free BALB/c male mice (The Jackson Laboratory)
Abbreviations: DHP, dihydropyridine; T-tubules, transverse tu-
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were immunized with a T-tubule-enriched membrane as
described (16).
Hybridomas were screened for the production of IgG
isotype by a solid-phase ELISA. Polyvinyl chloride 96-Well
microplates were sensitized with poly(L-lysine) (10 pg/ml)
followed by goat anti-mouse Fc fragment antibody (Jackson
ImmunoResearch, Avondale, PA) used at a dilution of 1/1000
in phosphate-buffered saline (Pi/NaCl), pH 7.4. After being
washed the plates were incubated with supernatant fluid from
the hybrid colonies and extensively washed. Alkaline phos-
phatase-linked goat anti-mouse Fc antibody (used at 1/1000
dilution in Pi/NaCl) was subsequently overlaid to permit
specific binding to IgG isotypes. After being washed with
P-/NaCl, wells were filled with 2,2'-azino-dl(3-ethylbenzthi-
azoline sulfonate) (Cappel Laboratories, Cochranville, PA)
solution, and IgG-producing colonies were identified by the
enzymatic color reaction. IgG-producing colonies were fur-
ther screened for those producing antibodies that bound
specifically with T-tubule-enriched membrane fractions. All
IgG-positive supernates were tested in a second ELISA
screen against several fractions of the two different mem-
brane types, respectively enriched in membranes originating
in either T-tubules or SR. Immulon plates (Flow Laborato-
ries) were coated first with poly(L-lysine) and incubated
overnight with membrane from the respective fraction [1-5
gg/ml in carbonate buffer, pH 9.6 (20)]. Supernates from
IgG-producing hybrid colonies were exposed overnight at
40C to the immobilized individual membrane preparations. A
peroxidase-linked goat anti-mouse IgG (Cappel, used at
1/1000 in 0.14 M Pi/NaCl at pH 7.4) was allowed to bind with
the primary antibody from the supernatant solutions. Anti-
bodies specific for the T-tubule-enriched membranes were
identified and selected after treating the peroxidase with the
substrate p-nitrophenyl phosphate (Sigma). The IgG-contain-
ing supernates were also selected for analysis by immuno-
cytochemistry as described below. Colonies producing the
desired antibody were cloned by limiting dilutions.
Immunocytochemical Analysis. Supernates containing an-
tibodies of the IgG isotype were examined against reactivity
with the triads as previously described (16) using an avidin-
biotin-complex immunoperoxidase stain with a Vectastain
staining kit (Vector Laboratories, Burlingame, CA) precisely
following the manufacturer's directions. The supernatant
fluids containing antibodies to be screened were exposed
overnight at 4°C to fixed muscle sections, or for 1 hr to fresh
muscle sections. 3-Amino-9-ethylcarbazole was used as a
peroxidase substrate (21). Staining was examined by light
microscopy. mAbs were isotyped as to immunoglobulin
heavy and light chains using a Boehringer Mannheim en-
zyme-linked immunoassay kit.
Purification ofmAb. mAbs were purified on staphylococcal
Protein A, covalently linked to Sepharose CL-4B beads
(Pharmacia). The mAb was eluted with 0.1 M sodium
citrate/citric acid at pH 5.0 (22) and detected at 280 nm. The
fractions containing the antibody were collected in 1-2 ml of
0.2 M Tris buffer, pH 7.5, and pooled. The antibody was
prepared for physiological studies (see below) by dialyzing it
extensively against 0.85% NaCl. Protein concentration was
done using bovine serum albumin as a standard (23).
Immunoaffinity Purification. Membrane fractions contain-
ing vesicles from T-tubules were solubilized with a buffer (24)
of 1.0% (wt/vol) digitonin (Fisher)/185 mM KCI/25 mM
4-(2-hydroxyethyl)-1-piperazineethane-sulfonic acid (Hepes)-
NaOH/1 mM EGTA, pH 7.4 containing the following pro-
tease inhibitors- 0.5 ug of antipain per ,ul, 0.5 ug of chymo-
statin per ml, 0.5 ,g of pepstatin per ml, 100 units of pertinin
per ml, 2 ,ugm of leupeptin per ml (Sigma) at 4°C for 2-3 hr.
The extract was clarified by centrifugation for 1 hr at 100,000
x g. The supernate containing the solubilized material was
passed overnight over an affinity column. A 0.5-ml bed
volume immunoaffinity column was prepared with activated
Affi-Gel 10 beads (Bio-Rad) on which mAb21-4 was cross-
linked following the manufacturer's specifications. After the
column was extensively washed.With solubilizing buffer, the
antigen was step-eluted with KCl (that increased in ionic
strength) in 25 mM Hepes-NaOH, pH 7.4/1 mM EGTA/0.3%
digitonin containing protease inhibitors. The eluate between
1 M and 2 M KCl was resolved after disulfide bond reduction
with 5% 2-mercaptoethanol by NaDodSO4/PAGE on discon-
tinuous 7.5% polyacrylamide -slab gel.
Recording of T-Tubule Ca2+ Channels. Ca2+ channel ac-
tivity from rabbit T-tubules was recorded from planar bilay-
ers using the vesicle fusion protocol previously established
for rat membranes (2). Vesicles were prepared essentially by
the same procedure described above for antigen preparation
(membrane fraction sedimenting at 22-27% sucrose after
dissociation of triads in high salt concentration). Vesicles
were stored at -80'C in 0.1 M KCI/0.3 M sucrose/5 mM
Na-Pipes, pH 6.8. Planar bilayers were formed from 20 mg of
lipid per ml of decane solution. An equimolar mixture of
bovine brain phosphatidylethanolamine and phosphatidylser-
ine (Avanti Biochemicals) was used in all experiments.
Membrane capacitance was 150-300 pF (300-,m-diameter
bilayer cup aperture). Current records were low-pass filtered
at 50-100 Hz using an 8-pole Bessel filter (Frequency
Devices, Haverhill, MA). All recordings were made using a
List EPC-7 patch clamp electrometer (List Electronics,
Darmstadt, F.R.G.) at a holding potential of 0 mV in cis
(voltage command side) 100 mM BaCl2/50 mM NaCl/0.1 AM
Bay K8644 and trans (ground side) 50 mM NaCl. Solutions
were buffered with 10 mM Hepes-Tris, pH 7.2/0.1 mM
EDTA. PN200-110, a DHP antagonist, was added to the cis
side from a 10 mM stock solution in methanol. Channels
usually insert with the cytoplasmic end in the cis chamber and
the external end in the trans chamber (26). Thus, Ba2+ current
at 0 mV was recorded as flowing outward through the
channel. Antibodies were screened by comparing records of
120 s in control conditions and comparable or longer sampling
times after the addition of antibody to the cis or trans bilayer
chamber. Records were digitized at 2 points per ms, stored in
10 megabyte Bernoulli magnetic disks (Vufax, Decatur, GA)
and analyzed on an IBM/AT computer as described (27, 28).
RESULTS
Localization of mAb21-4 in T-Tubules. The rabbit skeletal
muscle membrane fraction used in this study expressed a high
number of specific DHP binding sites (see Materials and
Methods), suggesting that it was enriched in T-tubule mem-
branes (13). mAbs against the T-tubule enriched membrane
fraction were produced by immunizing BALB/c mice and
subsequently fusing their spleen cells with P3 x 63Ag.8.6.5.3
mouse myeloma cells.
Using a solid-phase ELISA to screen for IgG production,
we identified in one fusion 63 colonies/1056 total outgrowths
that produced mouse IgG. Antibodies from these 63 hybrid-
omas were examined for binding potential on two different
membrane types. Vesicles from fractions enriched respec-
tively in T-tubules and SR membranes were used as antigens
on separate 96-well ELISA microplates. At this second level
of screening, we found 15 colonies that produced antibodies
against an antigen present only in the T-tubule-enriched
fractions. The 63 IgG antibodies were also examined by
immunocytochemistry with the goal of identifying a T-tubule
epitope. Because the triads are located in rabbit skeletal
muscle at the level of the A-I band junctions, we selected
hybridomas producing antibodies that exhibited a striated
granular doublet pattern at the light-dark band interface
comprising the A-I band junctions in longitudinal sections
(Fig. la). We selected against antibodies that stained the cell
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FIG. 1. Immunocytochemical staining pattern of mAb21-4. Mus-
cle was clamped in vivo with a muscle clamp and fixed in 2%
paraformaldehyde in Pi/NaCl, pH 7.4. Sections were stained via
avidin-biotin-complex immunoperoxidase and biotinylated horse
anti-mouse immunoglobulin using mAb21-4 as the primary antibody.
A cross-striated doublet pattern is evident at the A-I junctions
(light-dark band interface) consistent with the location of the triads
in rabbit (a, b). mAb21-4 did not stain the plasmalemma on cross
sections (d). The staining pattern of another antibody (Ab 40) is
included to demonstrate plasmalemma staining pattern (c). (b, x240;
a, c, and d X160.)
membrane (Fig. ic). The findings of the immunoperoxidase
assay and from the second ELISA were combined and used
to narrow the penultimate selection to six hybridoma colonies
for limiting dilution cloning. Our final criteria for selecting a
hybridoma for cloning was the production of an antibody of
the IgG isotype that exhibited the following: (i) high affinity
for T-tubule-enriched membranes by ELISA; (ii) doublet
granular peroxidase staining pattern at the level of the A-I
junctions (Fig. 1 a and b); (iii) absence of staining at the
plasmalemma ofmuscle cut in cross section (Fig. ld); and (iv)
changes in kinetics of Ca2" channel activity (see below).
Two hybridomas fulfilled the above criteria (hybridomas 21
and 24); however, only one (hybridoma 21) was successfully
cloned by limiting dilution. Clones that exhibited active
growth were screened by all the above assays. In this com-
munication the results from one clone (mAb2l-4) out of six
that satisfied our screening criteria are illustrated. mAb21-4
was of IgG1 isotype with K light chains and bound to
T-tubule-enriched membrane fractions. Reaction with mem-
branes from fractions enriched with SR was not detected.
mAb21-4 exhibited a doublet staining pattern at the A-I
junction by immunoperoxidase stain (Fig. 1 a and b). In
contradistinction to antibodies produced by another hybrid-
oma, (hybridoma 40, Fig. ic) mAb 21-4 did not stain the
plasmalemma on cross section (Fig. ld).
Immunopurification. mAb21-4 was produced at -4-5 ,g/
ml in culture fluids. The antibody was purified on Protein
A-Sepharose beads and used for immunoprecipitation at an
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approximate ratio of antibody/antigen (10:1) (wt/wt). Mr of
the antigen seemed to be within the range of 170,000 as
previously published (6, 7). The antigen was eluted in solu-
bilizing buffer between 1 M and 2 M KCl (Fig. 2, lane B). We
estimated the Mr of the eluted protein after disulfide bond
reduction by NaDodSO4/PAGE and silver staining. In a
series offour experiments mAb21-4 consistently precipitated
polypeptides of Mr values >175,000; 90,000; 55,000; and
34,000 (Fig. 2, lane B). Bands corresponding to major
well-characterized muscle membrane proteins were also
apparent on the gel from the eluted sample in Fig. 2. These
proteins were present in large amounts in the T-tubule-
enriched membrane fractions used as a source for the
immunoprecipitation studies (ref. 18 and Fig. 2, lane A).
However, we were able to eliminate these seemingly non-
specific contaminants in subsequent immunopurification ex-
periments (data not shown) by first passing solubilized
membranes on separate Affi-gel 10 columns on which albu-
min was immobilized.
Functional Effects of mAb21-4 on T-Tubule Ca2+ Channels.
Activation of T-tubule Ca2" channels by mAb21-4 followed
by block of activity by the DHP antagonist PN200-110 is
shown in Fig. 3. Kinetic effects of antibody were found more
prominent under conditions of low basal activity elicited by
submicromolar levels of Bay K8644. Under these conditions
and after a short incubation period, mAb21-4 increases the
frequency of openings as well as the mean open time. Hence,
this effect is- siiilar to the increase in channel activity
observed with higher concentrations of agonist (2). There are
numerous openings that in the presence of antibody appear to
have a unitary conductance smaller than the average mean
value; most of these appear to arise from fast opening
transitions induced by the antibody that are filtered by the
recording electronics. As shown in Fig. 3 Right, channels
activated by mAb21-4 are blocked by the antagonist PN200-
110 at similar doses reported for frog skeletal muscle Ca2+
currents in vivo%(11). Thus mAb21-4 does not appear to
compromise the DHP-binding site on the channel. Further
quantitation ofthe kinetic effects of antibody is shown in Fig.
4. Open channel current histograms (Fig. 4 Left) show that
the mean amplitude of openings in control channels after
addition of mAb21-4 and after inhibition by antagonist is
approximately the same. This is demonstrated by the fact that
peak amplitudes (x-axis) for the control, mAb21-4, and
PN200-110 conditions are all coincident. The larger ampli-
tude (y-axis) of the histogram in the presence of mAb21-4, as















FIG. 2. Polyacrylamide gel electrophore-
sis. Acrylamide (7.5%) slab gels are 1.5 mm
thick and they are silver stained. Sample
buffer contains 5% (vol/vol) mercaptoetha-
nol. Mr standards (-) (Pierce) 165,000;
155,000; 68,000; 39,000; and 21,500 are
shown on the left of lane A. (Lane A) T-
tubule-enriched membrane fraction. (Lane
B) Eluates from immunoaffinity column
between 1 M and 2 M KCI. The mAb con-
sistently precipitates polypeptides that re-
solve into bands of >175,000; 90,000; 55,000;
and 34,000, respectively (arrows). Unmarked
bands appeared to be nonspecifically bound
contaminants from major proteins present
in original membrane fractions. We were
able to eliminate these two bands in subse-
quent immunopurification experiments by
passing solubilized membranes first on albu-
min immobilized on Affi-Gel 10 columns.
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FIG. 3. Activation of T-tubule Ca2l channels by mAb21-4. Blocks of four records (noncontiguous) are shown for the indicated condition.
Control corresponds to activity elicited by 0.1 AM Bay K8644; mAb214 is the continuation of the same experiment above after cis addition (and
120-s incubation time) of 1.8 pg (0.6 ,g/ml, final concentration) of mAb21-4; and PN200-110 is the continuation of the same experiment after
cis addition (and 45-s incubation time) of 1 AM PN200-110. Calibration bars = 1 pA (vertical) and 400 ms (horizontal) are the same for all records.
open channels, reflects the increase in overall probability of
opening elicited by the antibody. When open probabilities are
scored as a function of time after incubation of channels with
mAb21-4 (Fig. 4 Right) it is apparent that the antibody
increases the frequency of both short and long events. During
a period of 100 s at each condition, the records are broken into
100-ms segments, and the fraction of open time in each
segment is shown as a vertical line of amplitude 0-1. Blank
spaces are those in which no openings occurred. mAb21-4
increases the overall number of open channels, particularly
those that give rise to lifetimes longer that the window size of
100 ms or longer-i.e., events with p = 1. This activity is
clearly reversed by the antagonist PN200-110.
DISCUSSION
We report the production of a mouse mAb (mAb21-4) that
modifies the kinetics ofthe voltage-dependent DHP-sensitive
Ca21 channel. The epitope recognized by the antibody is
associated with polypeptides that resolve on NaDodSO4/
PAGE at Mr values of 2 175,000; 90,000; 55,000; and 34,000.
1-
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This electrophoretic mobility is similar in part to that of
polypeptides associated with the 1,4-DHP receptor. When
the latter was purified with the aid of 1,4-DHPs, a large
polypeptide of -Mr 130,000-142,000 has been proposed to be
linked to smaller components of 50,000 and of 32,000-33,000
with internal disulfide bonds (5-8).
Antibodies against the DHP receptors associated with the
voltage-dependent Ca2+ channel have been previously pre-
pared (29), but to our knowledge, none has modulated
channel activity. The antibody reported here was prepared by
immunizing mice with a native protein, prepared by T-tubule
membrane fractionation. In preparations by others (29), the
putative channel was isolated from NaDodSO4-denatured
proteins resolved on polyacrylamide gels. It is conceivable
that under such conditions in the unfolding of protein fol-
lowing NaDodSO4 treatment the molecule would lose con-
formationally active sites. Antibodies prepared against such
denatured proteins may hence not affect function. Results
from a previous fusion, for which we used native membrane
proteins as antigens, yielded an antibody that also recognized
an epitope specific to the T-tubule (16). In that work we
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FIG. 4. Kinetic effects of mAb21-4 on T-tubule Ca2+ channels. Labels (Control, mAb21-4, and PN200-110) are for the same conditions
described for Fig. 3. (Left) Amplitude histograms ofopen channels constructed by sorting 44,000 samples of current (22 s of continuous recording
time) into 256 bins at a gain of 0.039 pA per bin. The y axis corresponds to bin content, and the x axis corresponds to the amplitude of open
channel currents under conditions specified. Samples that fall into baseline current (closed channel current) were subtracted to allow proper
scaling of those bins containing open channel current. Mean of the single peak current in control and PN200-110 and from the large peak in
mAb21-4 was within 0.52-0.56 pA; the mean of the secondary peak in mAb21-4 (1.12 pA) is due to the occurrence of two open channels. (Right)
Lifetime of single open channels monitored continuously during a period of 100 s. Multiple openings were excluded by appropriate setting of
threshold detectors. Records were divided into consecutive segments of 100 ms. Lifetime of channels in each segment is given in units of 100
ms-i.e., lines of length 1 correspond to lifetimes > 100 ms. Blank spaces correspond to segments without open channels.
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primarily screened with an immunocytochemical assay se-
lecting antibodies that exhibited a peroxidase staining pattern
in agreement with a T-tubule antigen localization. Used
alone, the assay seemed to preferentially identify antibodies
of the IgM isotype. Because of their size (-Mr, 1 x 106), such
antibodies produced high nonspecific background noise in
some studies. In this study we circumvented the problem by
initially screening with a heterologous antibody that recog-
nized the Fc region, characteristic of IgG types, of the
antibodies produced by the hybridomas.
The physiological interactions between the Ca2l channel
and mAb21-4 were best evaluated within 20 min after the
initial exposure time of the antibody to the antigen. This
observation is consistent with the kinetics described gener-
ally for mAb binding to membrane antigens (30). The asso-
ciation between the latter and their corresponding mAbs has
been described to be time dependent. This suggests to us that
mAb21-4 bound specifically to an antigenic determinant and
modified the channel function in the phospholipid bilayer
system.
Surface membranes of an adult skeletal muscle cell consist
of the plasmalemma that forms a sheath around the myofiber
and a surface-connected intracytoplasmic network, the T-
system or T-tubule (31). One significant difference between
these surface membrane domains is the preferential localiza-
tion of the Ca2+ channel in the T-tubule membrane (13, 14).
Though the role of the Ca2+ channel in controlling secretion
of hormones, release of neurotransmitters and Ca2+ avail-
ability in contraction of smooth and cardiac muscles has been
recognized (32), its function at the level of the T-tubule in
excitation-contraction coupling of skeletal muscle is not
clear; mAb21-4 may help to elucidate this role.
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